Medically prescribed products containing THC have shown value and safety in the management of a number of important clinical conditions, including debilitating chronic pain. Emyria who have seen over 3500 patients upholds evidence-based investigation and pharmacovigilance. Many patients are unfairly prohibited from access to these products by out-of-date driving legislation and testing that is not evidence-based. We need to Drive Change to prohibit driving with impairment, not driving with improvement.
It’s time to be kind and drive change for medicinal cannabis
Imagine having to choose between taking your legally prescribed medication and going to work,doing the school run or getting the shopping that week. Yes, week. This is the stark reality for many Australian medicinal cannabis patients because of the discriminatory drug-driving laws that still exist in most states. Current laws penalise the mere presence of […]Read more
Working and driving rights are human rights
If your prescribed medicine prevents you from driving and working, what does that mean for your human rights? The UK’s Cannabis Industry Council released a report this week into workplace issues for medicinal cannabis patients who are regarded as disabled under UK work, health and safety laws. Despite its specificity, it is a worthwhile read […]Read more